Skip to main content
SpringerLink
Log in

Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453–474.

    Article  PubMed  Google Scholar 

  2. Gyurkocza B, Sandmaier BM . Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Blood 2014; 124: 344–353.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Rosenberg AR, Syrjala KL, Martin PJ, Flowers ME, Carpenter PA, Salit RB et al. Resilience, health, and quality of life among long-term survivors of hematopoietic cell transplantation. Cancer 2015; 121: 4250–4257.

    Article  PubMed  Google Scholar 

  4. Flowers ME, Martin PJ . How we treat chronic graft-versus-host disease. Blood 2015; 125: 606–615.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB et al. Chronic graft-versus host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267–276.

    CAS  PubMed  Google Scholar 

  6. Atkinson K, Horowitz M, Van Bekkum DW, Gluckman E, Good RA, Jacobsen N et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459–2464.

    CAS  PubMed  Google Scholar 

  7. Eapen M, Rocha V, Sanz G, Scaradavou A, Zhang MJ, Arcese W et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol 2010; 11: 653–660.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG et al. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood 2015; 125: 1333–1338.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  PubMed  Google Scholar 

  10. Apperley J, Carreras E, Gluckman E, Masszi T . ESH-EBMT Handbook on Haemopoietic Stem Cell Transplantation. EBMT: Paris, France, 2012.

    Google Scholar 

  11. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.

    Article  CAS  PubMed  Google Scholar 

  12. Kaplan EL, Meier P . Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  13. Frassoni F, Labopin M, Gluckman E, Prentice HG, Gahrton G, Mandelli F et al. Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey. Acute Leukaemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia 1994; 8: 924–928.

    CAS  PubMed  Google Scholar 

  14. Lee SJ, Klar N, Weeks JC, Antin JH . Predicting costs of stem-cell transplantation. J Clin Oncol 2000; 18: 64–71.

    Article  CAS  PubMed  Google Scholar 

  15. Labopin M, Ruggeri A, Gorin NC, Gluckman E, Blaise D, Mannone L et al. Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France. Haematologica 2014; 99: 535–540.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Paris, France

    A Ruggeri, M Labopin & M Mohty

  2. Université Pierre et Marie Curie, Paris, France

    M Labopin, M Mohty & A Nagler

  3. Unità di Ematologia e trapianto di midollo, Ospedale San Raffaele, Milano, Italy

    F Ciceri

  4. Division of Hematology, Chaim Sheba Medical Center, Tel-Hashomer, Israel

    A Nagler

Authors
  1. A Ruggeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Labopin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F Ciceri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Mohty
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Nagler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Ruggeri.

Ethics declarations

Competing interests

The authors declare no conflict of interest

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruggeri, A., Labopin, M., Ciceri, F. et al. Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP–EBMT analysis on patients with AML in remission. Bone Marrow Transplant 51, 610–611 (2016). https://doi.org/10.1038/bmt.2015.305

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.305

  • Springer Nature Limited

This article is cited by

Search

Navigation